CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 95 filers reported holding CONCERT PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $480,000 | -0.6% | 40,000 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $483,000 | -3.8% | 40,000 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $502,000 | -15.5% | 40,000 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $594,000 | -11.7% | 40,000 | 0.0% | 0.00% | -33.3% |
| Q2 2018 | $673,000 | -26.5% | 40,000 | 0.0% | 0.00% | -25.0% |
| Q1 2018 | $916,000 | -11.5% | 40,000 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $1,035,000 | +75.4% | 40,000 | 0.0% | 0.00% | +100.0% |
| Q3 2017 | $590,000 | +5.7% | 40,000 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $558,000 | -18.2% | 40,000 | 0.0% | 0.00% | -33.3% |
| Q1 2017 | $682,000 | +65.5% | 40,000 | 0.0% | 0.00% | +50.0% |
| Q4 2016 | $412,000 | +2.0% | 40,000 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $404,000 | -10.0% | 40,000 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $449,000 | -17.8% | 40,000 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $546,000 | -64.0% | 40,000 | -50.0% | 0.00% | -33.3% |
| Q4 2015 | $1,518,000 | – | 80,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 1,932,123 | $44,246,000 | 4.48% |
| Ghost Tree Capital, LLC | 350,000 | $8,015,000 | 1.62% |
| INGALLS & SNYDER LLC | 1,322,062 | $30,275,000 | 1.48% |
| SENZAR ASSET MANAGEMENT, LLC | 199,139 | $4,561,000 | 1.44% |
| Matarin Capital Management, LLC | 285,450 | $6,536,805,000 | 0.49% |
| KNOTT DAVID M | 49,557 | $1,135,000 | 0.47% |
| Spark Investment Management LLC | 144,600 | $3,311,000 | 0.21% |
| PRINCETON CAPITAL MANAGEMENT LLC | 16,582 | $380,000 | 0.17% |
| TIVERTON ASSET MANAGEMENT LLC | 77,782 | $1,781,000 | 0.12% |
| CADENCE CAPITAL MANAGEMENT LLC | 82,240 | $1,883,000 | 0.12% |